Management of chloroquine resistant falciparum malaria.
D000328:Adult; D001927:Brain Diseases / Q000188:drug therapy; D002738:Chloroquine / Q000494:pharmacology*; D003622:Dapsone / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004487:Edema / Q000188:drug therapy; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D008887:Military Medicine; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000627:therapeutic use*; D011803:Quinine / Q000627:therapeutic use*; D014330:Tropical Medicine; D014481:United States; D014744:Vietnam
D003907:Dexamethasone; D002738:Chloroquine; D003622:Dapsone; D011803:Quinine; D011739:Pyrimethamine